CEO SUMMARY: Following the arrival of a new majority owner and a capital commitment of $50 million last year, Lakewood Pathology Associates has taken additional steps to pursue growth. Lakewood plans to acquire small to mid-sized companies that are complementary to its position in the anatomic pathology markets, particularly in the subspecialties of hematology and …
Lakewood Pathology Changes Leadership Read More »
